Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

EU flag

J&J gets EU green light for novel TB drug

Sirturo approved to treat multidrug resistant form of the disease

Novartis building

Novartis’ dermatology plans advance with Xolair approval

Green light for use in chronic spontaneous urticaria

Patients and HCPs turn first to Wikipedia

The online encyclopedia is now the leading source of medical information

- PMLiVE

Diabetes awards programme launches

QiC Diabetes 2014 premiered at Diabetes UK conference

INC Research acquires Middle Eastern CRO

Purchase of MEK Consulting expands its geographic footprint

Stallergenes appoints Christian Chavy CEO

He will replace Roberto Gradnik at the end of this month

Bristol-Myers Squibb (BMS) building

BMS’ novel HIV drug clears phase II trial

Entry inhibitor BMS-660368 moves closer to first-in-class approval

- PMLiVE

Lilly/Boehringer’s empagliflozin faces US approval delay

FDA cites manufacturing issues with the new diabetes drug

- PMLiVE

New VP for Merz North America

Gregory Bass to lead market access and reimbursement strategy

- PMLiVE

UDG buys KnowledgePoint360’s comms business

Deal is worth $144m

- PMLiVE

Edelman extends PR contract with Leo Pharma

Will continue to work together in Germany

- PMLiVE

Translational pharmacology: the key to ensuring safe and effective dosing

Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links